Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Ling, Morris
Item TypeName
Academic Article Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene.
Academic Article HPV DNA vaccines.
Academic Article Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins.
Academic Article Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen.
Academic Article CD8+ T cells, NK cells and IFN-gamma are important for control of tumor with downregulated MHC class I expression by DNA vaccination.
Academic Article Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen.
Academic Article Cancer immunotherapy using Sindbis virus replicon particles encoding a VP22-antigen fusion.
Academic Article Repeated DNA vaccinations elicited qualitatively different cytotoxic T lymphocytes and improved protective antitumor effects.
Academic Article Preventive and therapeutic vaccines for human papillomavirus-associated cervical cancers.
Academic Article Enhancement of sindbis virus self-replicating RNA vaccine potency by targeting antigen to endosomal/lysosomal compartments.
Academic Article Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand.
Academic Article Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen.
Academic Article Enhancing major histocompatibility complex class I antigen presentation by targeting antigen to centrosomes.
Academic Article Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen.
Academic Article Improving DNA vaccine potency by linking Marek's disease virus type 1 VP22 to an antigen.
Concept Vaccines, DNA
Search Criteria
  • Vaccines DNA
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.